Inhaled Corticosteroids Therapy to Reduce Mortality Rate of Pneumonia
According to an analysis conducted on 15,768 patients suffering from chronic obstructive pulmonary disease (COPD), the use of inhaled corticosteroids to treat pneumonia has brought down the mortality rate when compared to those who were not on these corticosteroids. As a matter of fact, it was earlier believed that the use of these corticosteroids in COPD patients actually increased their mortality rate. But, the latest study conducted which was conducted on the 15,768 patients admitted to the VA Hospitals has proved it otherwise.
All these patients were aged 65 or above and were admitted to the hospitals between the years 2002-2007. 52.5 percent of the admitted patients underwent therapy using inhaled corticosteroids while the rest were not treated with them. It was observed that the mortality rates between the two groups (treated and untreated), were significantly different and around 25 percent more in people who were not administered these steroids.